Hyponatremia associated with escitalopram use in a young woman

dc.authoridCaliyurt, Okan/0000-0002-0513-0619
dc.authorwosidCaliyurt, Okan/ABE-7339-2020
dc.contributor.authorCaliyurt, Okan
dc.contributor.authorDerici, Seda
dc.date.accessioned2024-06-12T11:03:37Z
dc.date.available2024-06-12T11:03:37Z
dc.date.issued2011
dc.departmentTrakya Üniversitesien_US
dc.description.abstractSelective serotonin re-uptake inhibitors have an increased usage in clinical practice and safe side effect profile. Hyponatremia is a rare but important and sometimes fatal side effect of SSRIs especially in elderly woman. In this paper, we report hyponatremia associated with escitalopram use in the youngest female patient in the literature so far. The reported case is a 17 year old female patient with Major Depressive Disorder developed acute hyponatremia. In the report we described early diagnosis of her hyponatremia and the connection with her medication. The treatment including cessation of escitalopram and fluid and electrolyte replacement was successful. In conclusion, it is clinically important to be aware of hyponatremia as an important side effect of SSRIs and young patients could also develop hyponatremia.en_US
dc.identifier.doi10.5455/bcp.20110706031715
dc.identifier.endpage160en_US
dc.identifier.issn1017-7833
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-79961056418en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage156en_US
dc.identifier.urihttps://doi.org/10.5455/bcp.20110706031715
dc.identifier.urihttps://hdl.handle.net/20.500.14551/21721
dc.identifier.volume21en_US
dc.identifier.wosWOS:000294399000012en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.publisherKure Iletisim Grubu A Sen_US
dc.relation.ispartofKlinik Psikofarmakoloji Bulteni-Bulletin Of Clinical Psychopharmacologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectHyponatremiaen_US
dc.subjectSSRIen_US
dc.subjectEscitalopramen_US
dc.subjectMajor Depressive Disorderen_US
dc.subjectSerotonin-Reuptake Inhibitorsen_US
dc.subjectAntidiuretic-Hormone Siadhen_US
dc.subjectInappropriate Secretionen_US
dc.subjectSymptomatic Hyponatremiaen_US
dc.subjectOlder-Adultsen_US
dc.subjectTherapyen_US
dc.subjectRisken_US
dc.titleHyponatremia associated with escitalopram use in a young womanen_US
dc.typeArticleen_US

Dosyalar